These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 20169010)

  • 1. Both the peroxisome proliferator-activated receptor delta agonist, GW0742, and ezetimibe promote reverse cholesterol transport in mice by reducing intestinal reabsorption of HDL-derived cholesterol.
    Briand F; Naik SU; Fuki I; Millar JS; Macphee C; Walker M; Billheimer J; Rothblat G; Rader DJ
    Clin Transl Sci; 2009 Apr; 2(2):127-33. PubMed ID: 20169010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced cholesterol absorption upon PPARdelta activation coincides with decreased intestinal expression of NPC1L1.
    van der Veen JN; Kruit JK; Havinga R; Baller JF; Chimini G; Lestavel S; Staels B; Groot PH; Groen AK; Kuipers F
    J Lipid Res; 2005 Mar; 46(3):526-34. PubMed ID: 15604518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ezetimibe inhibits hepatic Niemann-Pick C1-Like 1 to facilitate macrophage reverse cholesterol transport in mice.
    Xie P; Jia L; Ma Y; Ou J; Miao H; Wang N; Guo F; Yazdanyar A; Jiang XC; Yu L
    Arterioscler Thromb Vasc Biol; 2013 May; 33(5):920-5. PubMed ID: 23471229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LXR driven induction of HDL-cholesterol is independent of intestinal cholesterol absorption and ABCA1 protein expression.
    Kannisto K; Gåfvels M; Jiang ZY; Slätis K; Hu X; Jorns C; Steffensen KR; Eggertsen G
    Lipids; 2014 Jan; 49(1):71-83. PubMed ID: 24163219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. rHDL administration increases reverse cholesterol transport in mice, but is not additive on top of ezetimibe or cholestyramine treatment.
    Maugeais C; Annema W; Blum D; Mary JL; Tietge UJ
    Atherosclerosis; 2013 Jul; 229(1):94-101. PubMed ID: 23725986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peroxisome proliferator-activated receptor delta activation leads to increased transintestinal cholesterol efflux.
    Vrins CL; van der Velde AE; van den Oever K; Levels JH; Huet S; Oude Elferink RP; Kuipers F; Groen AK
    J Lipid Res; 2009 Oct; 50(10):2046-54. PubMed ID: 19439761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ezetimibe enhances macrophage reverse cholesterol transport in hamsters: contribution of hepato-biliary pathway.
    Uto-Kondo H; Ayaori M; Sotherden GM; Nakaya K; Sasaki M; Yogo M; Komatsu T; Takiguchi S; Yakushiji E; Ogura M; Nishida T; Endo Y; Ikewaki K
    Biochim Biophys Acta; 2014 Sep; 1841(9):1247-55. PubMed ID: 24989153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EP 80317, a CD36 selective ligand, promotes reverse cholesterol transport in apolipoprotein E-deficient mice.
    Bujold K; Mellal K; Zoccal KF; Rhainds D; Brissette L; Febbraio M; Marleau S; Ong H
    Atherosclerosis; 2013 Aug; 229(2):408-14. PubMed ID: 23880196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver-specific induction of Abcg5 and Abcg8 stimulates reverse cholesterol transport in response to ezetimibe treatment.
    Altemus JB; Patel SB; Sehayek E
    Metabolism; 2014 Oct; 63(10):1334-41. PubMed ID: 25060694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of intestinal cholesterol absorption with ezetimibe increases components of reverse cholesterol transport in humans.
    Davidson MH; Voogt J; Luchoomun J; Decaris J; Killion S; Boban D; Glass A; Mohammad H; Lu Y; Villegas D; Neese R; Hellerstein M; Neff D; Musliner T; Tomassini JE; Turner S
    Atherosclerosis; 2013 Oct; 230(2):322-9. PubMed ID: 24075764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model.
    Briand F; Tréguier M; André A; Grillot D; Issandou M; Ouguerram K; Sulpice T
    J Lipid Res; 2010 Apr; 51(4):763-70. PubMed ID: 19965597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ activation redirects macrophage cholesterol from fecal excretion to adipose tissue uptake in mice via SR-BI.
    Toh SA; Millar JS; Billheimer J; Fuki I; Naik SU; Macphee C; Walker M; Rader DJ
    Biochem Pharmacol; 2011 Apr; 81(7):934-41. PubMed ID: 21291868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niemann-pick C1-like 1 (NPC1L1) protein in intestinal and hepatic cholesterol transport.
    Jia L; Betters JL; Yu L
    Annu Rev Physiol; 2011; 73():239-59. PubMed ID: 20809793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anacetrapib and dalcetrapib differentially alters HDL metabolism and macrophage-to-feces reverse cholesterol transport at similar levels of CETP inhibition in hamsters.
    Briand F; Thieblemont Q; Muzotte E; Burr N; Urbain I; Sulpice T; Johns DG
    Eur J Pharmacol; 2014 Oct; 740():135-43. PubMed ID: 25008069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ApoE promotes hepatic selective uptake but not RCT due to increased ABCA1-mediated cholesterol efflux to plasma.
    Annema W; Dikkers A; Freark de Boer J; Gautier T; Rensen PCN; Rader DJ; Tietge UJF
    J Lipid Res; 2012 May; 53(5):929-940. PubMed ID: 22383685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic demonstration of intestinal NPC1L1 as a major determinant of hepatic cholesterol and blood atherogenic lipoprotein levels.
    Xie P; Zhu H; Jia L; Ma Y; Tang W; Wang Y; Xue B; Shi H; Yu L
    Atherosclerosis; 2014 Dec; 237(2):609-17. PubMed ID: 25463095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.
    Valasek MA; Repa JJ; Quan G; Dietschy JM; Turley SD
    Am J Physiol Gastrointest Liver Physiol; 2008 Oct; 295(4):G813-22. PubMed ID: 18718997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ezetimibe restores biliary cholesterol excretion in mice expressing Niemann-Pick C1-Like 1 only in liver.
    Tang W; Jia L; Ma Y; Xie P; Haywood J; Dawson PA; Li J; Yu L
    Biochim Biophys Acta; 2011 Sep; 1811(9):549-55. PubMed ID: 21683156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPAR-β/δ activation promotes phospholipid transfer protein expression.
    Chehaibi K; Cedó L; Metso J; Palomer X; Santos D; Quesada H; Naceur Slimane M; Wahli W; Julve J; Vázquez-Carrera M; Jauhiainen M; Blanco-Vaca F; Escolà-Gil JC
    Biochem Pharmacol; 2015 Mar; 94(2):101-8. PubMed ID: 25662586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not Niemann-Pick C1-like 1.
    Moussa M; Landrier JF; Reboul E; Ghiringhelli O; Coméra C; Collet X; Fröhlich K; Böhm V; Borel P
    J Nutr; 2008 Aug; 138(8):1432-6. PubMed ID: 18641187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.